| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Axsome Therapeutics, Inc. | Chief Financial Officer | Common Stock | 42.2K | $5.53M | $131.07 | 14 Feb 2025 | Direct |
| Axsome Therapeutics, Inc. | Chief Financial Officer | Performance Stock Units | 9.42K | $1.24M | $131.07 | 24 Feb 2025 | Direct |
| Axsome Therapeutics, Inc. | Chief Financial Officer | Restricted Stock Units | 9.42K | $1.24M | $131.07 | 21 Feb 2025 | Direct |
| Axsome Therapeutics, Inc. | Chief Financial Officer | Common Stock | 488 | $64K | $131.07 | 13 Feb 2025 | Indirect |
| Axsome Therapeutics, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 0 | $0 | $3.50 | 14 Feb 2025 | Direct |
| Axsome Therapeutics, Inc. | Chief Financial Officer | Employee Stock Option (Right to Buy) | 9.52K | 21 Feb 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AXSM | Axsome Therapeutics, Inc. | 21 Feb 2025 | 3 | $0 | 4 | Chief Financial Officer | 25 Feb 2025, 19:54 |
| AXSM | Axsome Therapeutics, Inc. | 13 Feb 2025 | 6 | -$1.95M | 4 | Chief Financial Officer | 14 Feb 2025, 21:20 |
| AXSM | Axsome Therapeutics, Inc. | 27 Feb 2024 | 2 | $0 | 4 | CHIEF FINANCIAL OFFICER | 29 Feb 2024, 18:25 |
| AXSM | Axsome Therapeutics, Inc. | 02 Mar 2023 | 2 | $0 | 4 | CHIEF FINANCIAL OFFICER | 06 Mar 2023, 17:14 |
| AXSM | Axsome Therapeutics, Inc. | 04 Mar 2022 | 2 | $0 | 4 | CHIEF FINANCIAL OFFICER | 08 Mar 2022, 16:02 |
| AXSM | Axsome Therapeutics, Inc. | 18 Nov 2021 | 4 | $33.7K | 4 | CHIEF FINANCIAL OFFICER | 22 Nov 2021, 06:31 |
| AXSM | Axsome Therapeutics, Inc. | 12 Nov 2021 | 1 | $0 | 4 | CHIEF FINANCIAL OFFICER | 15 Nov 2021, 18:55 |